NCT01008683Unknown不适用
Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 300
- 试验地点
- 1
研究概览
简要总结
Stem cell and and heart transplant patients will receive pandemic H1N1 influenza vaccination according to the clinical guidelines.
In these patients the investigators will measure the specific antibody production.
详细描述
Stem cell and and heart transplant patients will receive pandemic H1N1 influenza vaccination according to the clinical guidelines. Two doses will be given, in 3-week interval.
In these patients we will measure the specific antibody production. Blood sample 5 ml will be drawn before the first vaccine, before the second, and 3-4 weeks after the 2nd dose.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- — 至 80 Years(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Stem cell and and heart transplant patients who will receive pandemic H1N1 influenza vaccination according to the clinical guidelines.
排除标准
- •Patients with unstable grafts.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant PatientsOrgan TransplantationNCT01254955Sahlgrenska University Hospital, Sweden
Unknown
不适用
Assessment of Safety and Immunogenicity of Intradermal Unadjuvanted Portion of Pandemrix® Via a Microneedle Device With Intramuscular Adjuvanted Pandemrix® as ReferenceHealthyNCT01039623Hadassah Medical Organization200
Unknown
2 期
Vaccination Against Influenza H1N1 in Rheumatic DiseasesRheumatic DiseasesInfluenzaNCT01006681Tel-Aviv Sourasky Medical Center400
Unknown
不适用
Efficacy and Safety of Vaccination Against Influenza H1N1 in Patients With Inflammatory Bowel Diseases (IBD) Treated Immunomodulators and BiologicsInfluenza H1N1NCT01019837Tel-Aviv Sourasky Medical Center200
Unknown
3 期
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 MonthSwine-origin A/H1N1 InfluenzaInfluenzaNCT01040078Centers for Disease Control and Prevention, China900
